Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and two new agreements signed

15 Aug 2023 07:00

RNS Number : 2892J
Gelion PLC
15 August 2023
 

15 August 2023

Gelion plc

("Gelion" or the "Company")

 

Trading update and new agreements for progressing Zinc-based Energy Storage solution

 

Agreements signed with The University of Sydney and Professor Yuan Chen

 

Gelion (AIM: GELN), the Anglo-Australian battery innovator, today provides an update on the Group's trading for the year ended 30 June 2023 and announces the signing of two agreements with The University of Sydney and Professor Yuan Chen for Gelion's Advanced Cathode Project, accelerating progress towards its Zinc-based Energy Storage Solution. The agreements are to utilise Gelion's recent zinc anode performance breakthroughs leading to Gelion's next generation of energy solutions - Gelion's Gen 5 Zinc Hybrid Cell.

 

Gelion's advanced Zinc technology offers not only a low cost, safe and robust chemistry, but by deploying it in a novel bromine-free hybrid cell format it also offers an inherently non-toxic improved power capability (higher currents) and cycle life performance. Initially, it is expected to be highly competitive against lead acid batteries in applications such as Stand-Alone Power Systems (SAPs), Voltage Regulation, Telecom, and home Uninterrupted Power Supplies (UPS), with market size estimated to be over US$7 billion. Following additional later development, Long Duration Energy Storage (LDES) applications will be targeted as well.

 

Trading Update

 

Unaudited financial results for the year ended 30 June 2023 are expected to be ahead of current guidance:

·

Revenues for the year are expected to be £2.0m ahead of current guidance of £1.7m.

·

Adjusted EBITDA loss* expected to be approximately £6.0m, lower than guidance of £6.4m.

·

Net cash at 30 June 2023 was £7.3m, marginally higher than the current guidance of £7.1m. The balance at 30 June 2023 is post the £3.0m cash used to acquire the Johnson Matthey Intellectual Property (IP) portfolio in March 2023.

·

Since March 2023, the Company has been focused on reducing costs and has taken steps to reduce cash consumption by c. £1.0m on an annualised basis.

 

*Adjusted EBITDA loss (defined as the Earnings Before Interest, Tax, Depreciation, Amortisation, & other non-recurring items)

 

Highlights of agreements with the University of Sydney to accelerate progress of Gen 5 Zinc Hybrid Cell

 

·

Signed two agreements with The University of Sydney, centered on Professor Yuan Chen and his Laboratory for Advanced Carbon Research. Gelion's Advanced Cathode Project will work to jointly progress an advanced cathode for its Gen 5 Zinc Hybrid Cell. These research streams are expected to generate commercially relevant prototypes by the end of 2023.

·

This programme leverages the learnings from the manufacture of 1,200 Zinc Bromide (ZnBr2) batteries at the pilot manufacturing facility in February 2023 and the Battery Management Systems (BMS) development since then, as part of the R&D pathway to commercialisation.

·

Professor Chen will act as a consultant to Gelion, providing his guidance and experience to accelerate progress in both technical and commercial aspects of the Gen 5 Zinc Hybrid Cell development.

·

Any IP developed during the project will be retained by Gelion.

 

The two agreements follow the announcement on 6 July 2023, regarding the achievement of significantly improved zinc plating behaviour that reduces cell maintenance requirements. This breakthrough resulted from the 12‑month ZnBr2 research programme (R&D Programme) launched earlier this year to achieve all three key objectives in the one design simultaneously, i.e. safety, energy density, and cost.

 

Due to this zinc technology innovation, Gelion was able to identify and migrate to a zinc-based energy storage solution that is bromine-free, i.e. a Zinc Hybrid Cell. It will continue to validate this technology for the remainder of 2023, consistent with the timelines communicated for Gelion's R&D Programme earlier this year.

 

Commenting on the update, John Wood, CEO said: "Zinc is positioned to be a very important battery element due to its abundance and low cost. We have now modified the direction of our Gelion Zinc cell activities toward a hybrid cell that is designed to both be readily scalable because of its safety, cost, and the materials chosen, while delivering features important to the market including robustness, a wide temperature tolerance, the ability to use a wide range of charge and be stored and transported in a discharged state.

 

"We are very fortunate to be able to work with Professor Yuan Chen to incorporate his research, understanding, and experience to move both quickly and directly towards our goals. We are conducting an accelerated validation until the end of this year before setting out our zinc commercialisation plan and will update soon after. We are very confident this is a key positive inflection point in our zinc activities.

 

"I am also very pleased with the progress we have made so far, be it the strategic Lithium Sulfur IP acquisition, plans to expand the Lithium Sulfur R&D facility, pivoting from Zinc Bromine to Gelion's Gen 5 Zinc Hybrid Cell, or securing the collaboration with The University of Sydney. These are all a result of focused efforts on product refinement to reduce costs to market, improve processes and speed to market. I am also delighted to report that we have slowed down our cash consumption considerably and will provide an update on the cost saving measures and the 12-month plan at the time of announcing our final results."

 

Professor Chen commented: "I am excited to be part of this programme as all my research aims to develop efficient, cost-effective, and reliable energy storage solutions. It is a perfect fit, underpinning Gelion's commercialisation in a highly prospective space."

 

Background

On 6 July 2023, the Company announced that it had identified a Zinc Energy Storage Solution which will comprise a zinc cell with an alternate cathode technology to progress beyond challenges that had been identified with dendritic growth and Bromine sequestration that were resulting in higher costs and safety issues under forcing conditions. 

 

Continuing with its progress on the R&D programme, the new Advanced Cathode Project will aim to develop an advanced cathode for Gelion's Gen 5 Zinc Hybrid Cell with key research on carbon-based cathode materials, current collectors, and advancements in electrolyte formulations that will directly contribute to increased safety, higher energy density, and cost improvements.

 

Professor Chen has a PhD from Yale University and is a Fellow of The Royal Society for Chemistry (UK), the Royal Australian Chemical Institute, and the Institution of Chemical Engineers. He also serves as editor for a highly regarded scientific journal Carbon (Elsevier) and has over 20 years of experience in researching energy storage related materials, including zinc-based systems.

 

The collaboration will initially run for up to two years as part of an intensive commissioned R&D project including the initial validation of the technology in 2023 followed by ongoing development work to progress to commercialisation. This project will have combined teams from The University of Sydney and Gelion's experienced zinc cell research team as well as strong involvement from Gelion's Founder and Principal Technology Advisor, Professor Thomas Maschmeyer. Importantly, the new system will leverage the progress achieved with Gelion's zinc anode, prismatic cell design, and systems, and intellectual property rights relating to key deliverables of the advanced cathode project will be retained by Gelion.

 

CONTACTS

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

Alma PR (Financial PR Adviser)

Justine James

Hannah Campbell

Will Ellis Hancock

+44 20 3405 0205

gelion@almapr.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFIITLISLIV
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.